Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Cash from Financing Activities (2021)

Medicinova (MNOV) has disclosed Cash from Financing Activities for 3 consecutive years, with $38699.0 as the latest value for Q4 2021.

  • On a quarterly basis, Cash from Financing Activities changed N/A to $38699.0 in Q4 2021 year-over-year; TTM through Sep 2022 was $678048.0, a 97.18% decrease, with the full-year FY2025 number at $244018.0, changed N/A from a year prior.
  • Cash from Financing Activities was $38699.0 for Q4 2021 at Medicinova, down from $249611.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $20.1 million in Q1 2021 to a low of $38699.0 in Q4 2021.